论文部分内容阅读
目的探究在小儿支原体肺炎治疗过程中给予阿奇霉素序贯疗法的可行性和价值。方法 68例小儿支原体肺炎患儿,采取随机数字表分为观察组和对照组,各34例。对照组患儿给予阿奇霉素持续静脉滴注治疗,观察组患儿采取阿奇霉素序贯疗法,统计和分析两组患者的疗效差异。结果观察组的治疗总有效率为97.06%,对照组治疗总有效率为70.59%,观察组的临床疗效更显著,差异具有统计学意义(P<0.05)。结论小儿支原体肺炎在治疗过程中选取阿奇霉素序贯疗法治疗,有利于患儿症状缓解,疗效显著,值得临床推荐和应用。
Objective To explore the feasibility and value of sequential therapy of azithromycin in the treatment of pediatric mycoplasma pneumonia. Methods A total of 68 children with mycoplasma pneumonia were randomly divided into observation group and control group with 34 cases in each group. Patients in the control group were given azithromycin for continuous intravenous infusion. The patients in the observation group were treated with azithromycin sequential therapy, and the differences between the two groups were statistically analyzed. Results The total effective rate of the observation group was 97.06%, while that of the control group was 70.59%. The clinical efficacy of the observation group was more significant (P <0.05). Conclusion Mycoplasma pneumonia in children during the treatment of selected sequential treatment of azithromycin is conducive to children with symptoms, significant effect, worthy of clinical recommendations and applications.